Posted on 12/13/2022 12:10:30 PM PST by ChicagoConservative27
A pair of Democrats are pressing Pfizer about the company’s plans to raise the price of its COVID-19 vaccine.
In a letter to Pfizer CEO Albert Bourla, Sen. Elizabeth Warren (D-Mass.) and Rep. Peter Welch (D-Vt.), a senator-elect, slammed the move as “pure and deadly greed” and expressed concern it could result in other vaccine manufacturers, such as Moderna and Novavax, raising the prices of their vaccines.
The Democrats asked for information about the justification for the price increase and the impact of the increase on Americans who could be required to pay high out-of-pocket costs for the vaccine.
“We urge you to back off from your proposed price increases and ensure COVID-19 vaccines are reasonably priced and accessible to people across the United States,” Warren and Welch wrote.
(Excerpt) Read more at thehill.com ...
Fauxcahontas will shut up about this when she gets her cut.
😳😳😳😳🤔. On the price hike? How about lack if effectiveness and safeness? 🔬🤔😵🚫😷💉🐎💩
Acting like they’re helping the American people while their hands are in the till.
This explains why comirnaty isn’t available: “Pfizer expects to roughly quadruple the price of its COVID-19 vaccine to between $110 and $130 per dose once the U.S. government’s purchasing program ends early next year.”
Who would pay $110 to $130 when it’s free from the government?
bourla used to be a heroin dealer
he knows what he is doing
I always thought the government was footing the bill until I got my Medicare statement showing that Medicare paid $110 bucks for the initial j&j vaccine shot and the booster...
Government freebies die on 1-1-2023.
Government was paying $30 a dose.
Take it easy on ‘em....they’re just following the Gillette Safety Razor marketing model.
/s
Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.